Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Borg

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Oncogene|May 1, 1993
The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptorF Galland, A Karamysheva, M J Pebusque, et al.
Parkinsonism & Related Disorders|February 16, 2010
Attentional and perceptual impairments in Parkinson's disease with visual hallucinationsJanneke Koerts, Maarten A J P Borg, Anne Marthe Meppelink, et al.
The Journal of Biological Chemistry|May 31, 1996
Interaction with the phosphotyrosine binding domain/phosphotyrosine interacting domain of SHC is required for the transforming activity of the FLT4/VEGFR3 receptor tyrosine kinaseE Fournier, O Rosnet, S Marchetto, et al.
Applied Optics|January 6, 2023
Quantitative focused laser differential interferometry with hypersonic turbulent boundary layersElizabeth K Benitez, Matthew P Borg, J Luke Hill, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|February 13, 2013
Outcomes after ultrasound-guided platelet-rich plasma injections for chronic tendinopathy: a multicenter, retrospective reviewKenneth Mautner, Ricardo E Colberg, Gerard Malanga, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 10, 1999
Molecular analysis of the X11-mLin-2/CASK complex in brainJ P Borg, M O Lõpez-Figueroa, M de Taddèo-Borg, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1997
Resistance to neuroglycopenia: an adaptive response during intensive insulin treatment of diabetesT W Jones, W P Borg, M A Borg, et al.
Nature Cell Biology|July 6, 2000
ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptorJ P Borg, S Marchetto, A Le Bivic, et al.
European Journal of Clinical Nutrition|October 20, 2001
The validity of predicted body fat percentage from body mass index and from impedance in samples of five European populationsP Deurenberg, A Andreoli, P Borg, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 18, 2007
Vascular events after liver transplantation: a long-term follow-up studyMaarten A J P Borg, Egbert-Jan van der Wouden, Wim J Sluiter, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Oncogene|May 1, 1993
The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptorF Galland, A Karamysheva, M J Pebusque, et al.
Parkinsonism & Related Disorders|February 16, 2010
Attentional and perceptual impairments in Parkinson's disease with visual hallucinationsJanneke Koerts, Maarten A J P Borg, Anne Marthe Meppelink, et al.
The Journal of Biological Chemistry|May 31, 1996
Interaction with the phosphotyrosine binding domain/phosphotyrosine interacting domain of SHC is required for the transforming activity of the FLT4/VEGFR3 receptor tyrosine kinaseE Fournier, O Rosnet, S Marchetto, et al.
Applied Optics|January 6, 2023
Quantitative focused laser differential interferometry with hypersonic turbulent boundary layersElizabeth K Benitez, Matthew P Borg, J Luke Hill, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|February 13, 2013
Outcomes after ultrasound-guided platelet-rich plasma injections for chronic tendinopathy: a multicenter, retrospective reviewKenneth Mautner, Ricardo E Colberg, Gerard Malanga, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 10, 1999
Molecular analysis of the X11-mLin-2/CASK complex in brainJ P Borg, M O Lõpez-Figueroa, M de Taddèo-Borg, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1997
Resistance to neuroglycopenia: an adaptive response during intensive insulin treatment of diabetesT W Jones, W P Borg, M A Borg, et al.
Nature Cell Biology|July 6, 2000
ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptorJ P Borg, S Marchetto, A Le Bivic, et al.
European Journal of Clinical Nutrition|October 20, 2001
The validity of predicted body fat percentage from body mass index and from impedance in samples of five European populationsP Deurenberg, A Andreoli, P Borg, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 18, 2007
Vascular events after liver transplantation: a long-term follow-up studyMaarten A J P Borg, Egbert-Jan van der Wouden, Wim J Sluiter, et al.
Pageof 7